{
    "nct_id": "NCT04018872",
    "official_title": "A Phase II Trial Evaluating the Effectiveness of Itraconazole in Improving Pathologic Complete Response Rates in Patients With Esophageal Cancer Through Inhibition of the Hedgehog and AKT Signaling Pathways",
    "inclusion_criteria": "* Patients diagnosed with localized (locoregional) esophageal cancer\n* Patients diagnosed with localized (locoregional) gastroesophageal junction cancer\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients unwilling or unable to provide informed consent\n* Patients with QTc>450ms\n* Patients with a history of symptomatic congestive heart failure\n* Patients with LFT's>3xULN\n* Patients who are pregnant\n* Patients with a known allergy to itraconazole",
    "miscellaneous_criteria": ""
}